Financial Performance - The basic earnings per share for 2024 is 0.3443 yuan, a decrease of 20.7% compared to 2023's 0.4342 yuan [1] - The net profit for 2024 is 0.5 billion yuan, down 20.63% from 0.63 billion yuan in 2023 [1] - The return on equity for 2024 is 6.47%, a decline of 19.43% from 8.03% in 2023 [1] - The total operating revenue for 2024 is 4.9 billion yuan, a slight decrease of 2.78% from 5.04 billion yuan in 2023 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 33.8976 million shares, accounting for 49.29% of the circulating shares, with a change of 311,100 shares from the previous period [1] - The largest shareholder, Tang Ling, holds 15.2707 million shares, representing 22.20% of the total share capital, with no change [2] - The second-largest shareholder, Li Da, holds 5.1188 million shares, accounting for 7.44%, also with no change [2] Dividend Distribution - The company has announced a dividend distribution plan of 3.2 yuan per share (including tax) [3]
美农生物:2024年报净利润0.5亿 同比下降20.63%